Literature DB >> 24787289

Animal models and the tumor microenvironment: studies of tumor-host symbiosis.

Daniel Lindner1.   

Abstract

The contributions of murine models to elucidation of processes central to tumor growth are reviewed. Localized acidosis, increased interstitial pressure, perturbations in structure and function of the extracellular matrix, hypoxia, angiogenesis, and co-optation of the immune response are all phenomena that promote tumor survival and metastasis. The use of animal models is critical to understanding the pathophysiology of these processes and the development of more effective cancer therapies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24787289      PMCID: PMC4008865          DOI: 10.1053/j.seminoncol.2014.02.004

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  78 in total

Review 1.  Molecular pathways linking inflammation and cancer.

Authors:  A Mantovani
Journal:  Curr Mol Med       Date:  2010-06       Impact factor: 2.222

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

4.  IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.

Authors:  Kevin L Taylor; Rhonda K Oates; Ron Grane; Douglas W Leaman; Ernest C Borden; Daniel J Lindner
Journal:  J Interferon Cytokine Res       Date:  2006-05       Impact factor: 2.607

Review 5.  CD36-TSP-HRGP interactions in the regulation of angiogenesis.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes.

Authors:  Dmitriy Lukashev; Boris Klebanov; Hidefumi Kojima; Alex Grinberg; Akiko Ohta; Ludmilla Berenfeld; Roland H Wenger; Akio Ohta; Michail Sitkovsky
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

Review 7.  Bidirectional regulation of macrophage function by TGF-beta.

Authors:  G S Ashcroft
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

8.  A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.

Authors:  Kyoko Hida; Michael Klagsbrun
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

Review 9.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

10.  A cancer-recognizable MRI contrast agents using pH-responsive polymeric micelle.

Authors:  Kyoung Sub Kim; Wooram Park; Jun Hu; You Han Bae; Kun Na
Journal:  Biomaterials       Date:  2013-10-15       Impact factor: 12.479

View more
  7 in total

1.  Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents.

Authors:  Michiel Kroesen; Ingrid C Brok; Daphne Reijnen; Maaike A van Hout-Kuijer; Ingrid S Zeelenberg; Martijn H Den Brok; Peter M Hoogerbrugge; Gosse J Adema
Journal:  Cancer Immunol Immunother       Date:  2015-02-17       Impact factor: 6.968

2.  Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells.

Authors:  Jinpeng Li; Hao Liu; Jieping Yu; Honggang Yu
Journal:  Mol Med Rep       Date:  2015-02-16       Impact factor: 2.952

3.  Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging.

Authors:  Amy F Martinez; Samuel S McCachren; Marianne Lee; Helen A Murphy; Caigang Zhu; Brian T Crouch; Hannah L Martin; Alaattin Erkanli; Narasimhan Rajaram; Kathleen A Ashcraft; Andrew N Fontanella; Mark W Dewhirst; Nirmala Ramanujam
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

Review 4.  Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer.

Authors:  Margarite D Matossian; Alexandra A Giardina; Maryl K Wright; Steven Elliott; Michelle M Loch; Khoa Nguyen; Arnold H Zea; Frank H Lau; Krzysztof Moroz; Adam I Riker; Steven D Jones; Elizabeth C Martin; Bruce A Bunnell; Lucio Miele; Bridgette M Collins-Burow; Matthew E Burow
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-09-24

5.  Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response.

Authors:  Jared M Newton; Jose H Flores-Arredondo; Sarah Suki; Matthew J Ware; Martyna Krzykawska-Serda; Mahdi Agha; Justin J Law; Andrew G Sikora; Steven A Curley; Stuart J Corr
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

6.  Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics.

Authors:  Xiaoying Ye; Brian T Luke; Bih-Rong Wei; Jan A Kaczmarczyk; Jadranka Loncarek; Jennifer E Dwyer; Donald J Johann; Richard G Saul; Dwight V Nissley; Frank McCormick; Gordon R Whiteley; Josip Blonder
Journal:  Oncotarget       Date:  2018-05-29

Review 7.  Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.

Authors:  Bowen Du; Joong Sup Shim
Journal:  Molecules       Date:  2016-07-22       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.